Claudia Ines Chamas, Ben Prickril (National Cancer Institute), & Joshua D. Sarnoff (DePaul University College of Law) have posted Intellectual Property and Medicine: Towards Global Health Equity (Intellectual Property and Human Development (Tzen Wong & Graham Dutfield Eds., Cambridge Univ. Press 2010)) on SSRN. Here is the abstract:
This chapter first provides an overview of issues and trends where IP intersects with access to health care and health-related products. Some issues and trends of key relevance to developing countries are highlighted in Section 1. This is followed by a discussion of important initiatives at the international and local levels to deal with the severe problem of resurgent and "neglected" diseases (so called for the lack of research investment targeted at them) in developing countries and least developed countries. Strategies adopted at the international level, particularly at the World Health Organization (WHO), are discussed in Section 2, along with alternative innovation models developed largely through public-private partnerships for research and development of new vaccines and medicines for HIVAIDS and other diseases (see further Appendix B). In Section 3, some future scenarios published by international and regional entities in relation to IP and health are described, along with analysis of their implications for human development.